Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. Chromatography Standards
  5. Drug Standards
  6. 01001636

CERILLIANT™ Methedrone Hydrochloride Solution, 1.0 mg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™

Catalog No. 01001636 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-636 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-636 Supplier MilliporeSigma Supelco Supplier No. M1471ML

Due to product restrictions, please to purchase or view availability for this product.

Description

Certified reference material

Methedrone is a synthetic stimulant of the phenethylamine, amphetamine, and cathinone classes. Significant abuse of this new designer drug, also known as 4-methoxymeth-cathinone, methoxyphedrine, or bk-PMMA, has been reported within the last year in Sweden, the UK, Poland and states including Louisiana and Kentucky.
TRUSTED_SUSTAINABILITY

Specifications

Packaging Ampule
CAS 879665-92-6
Flash Point 9.7°C (49.5°F) - closed cup
Concentration 1.0 mg/mL in methanol (as free base)
Linear Formula C11H16ClNO2
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Synonym 4-Methoxymethcathinone hydrochloride
Quantity 1 mL
Formula Weight 229.7

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.